Back to Journals » Risk Management and Healthcare Policy » Volume 13

Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study

Total article views   HTML views PDF downloads Totals
9,821 Dovepress* 8,774+ 1,236 10,010
PubMed Central* 1,047 318 1,365
Totals 9,821 1,554 11,375
*Since 22 January 2020

View citations on PubMed Central and Google Scholar